Janney Analyst Yun Zhong, When Asked About Strength In Insys Therapeutics, Tells Benzinga 'I Would Consider Any Movement To Be Purely Random', Noting That Co. Recently Filed For Bankruptcy And Will Soon Be Delisted From Nasdaq
Benzinga Newsdesk